Nelson DA, Vates TS, Thomas JR. Complications from intrathecal steroid therapy in patients with multiple sclerosis. Neurology 1972;22:454.

Nelson DA, Vates TS, Thomas RB. Complications from intrathecal steroid therapy in patients with multiple sclerosis. Acta Neurologica Scandinavica 1973;49:176-188.

Nelson DA, Vates TS, Thomas RB. Complications from intrathecal steroid therapy in patients with multiple sclerosis. Yearbook Neurology, Neurosurgery and Psychiatry 1975;194-195.

Arachnoiditis from intrathecally given corticosteroids in the treatment. of multiple sclerosis. Arch Neurol 1976;33: 373.

Nelson DA, Abel R. Bernat JL. Complications from methylprednisolone acetate (DepoMedrol) when injected into the orbit, subarachnoid or subdural spaces. Del Med J 1977;49331-343.

Methylprednisolone acetate. Arch Neurol 1979;36: 661-662.

Dangers from methylprednisolone acetate therapy by intraspinal injection, (Neurologic Review). Arch Neurol 1988;45: 804-806.

Safety of intrathecal steroids in multiple sclerosis (A reply). Arch Neurol 1989;46:718-719.

Perceived dangers from intraspinal steroid injections (A reply) Arch Neurol 1989;46: 719-721.

Dangers from Methylprednisolone acetate therapy by intraspinal injection (A reply). Arch Neurol 1989;46;721-722.

Pain in multiple sclerosis, Neurology 1989;39;1000-1001.

Dangers from intraspinal steroid injections. Arch Neurol 1990;47:255.

Further warnings from Australia concerning intraspinal steroids. Arch Neurol 1990;48:25 9.

Intraspinal therapy using methylprednisolone acetate, twenty-three years of clinical controversy. Spine 1993;18: 278-286.